Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 7/2021

01-07-2021 | COPD Exacerbation | Bottom Line Summary

CRP-Guided Antibiotic Therapy for Acute COPD Exacerbation: a Randomized Control Trial

Authors: Jocelyn A. Carter, MD, MPH, Harry B. Burke, MD, PhD

Published in: Journal of General Internal Medicine | Issue 7/2021

Login to get access

Excerpt

The use of CRP testing in patients with COPD exacerbations decreased antibiotic use and did not impact patient‐reported quality of life. …
Literature
1.
Wheaton AG, Cunningham TJ, Ford ES, Croft JB. Employment and activity limitations among adults with chronic obstructive pulmonary disease United States, 2013. MMWR Morb Mortal Wkly Rep. 2015;64:289-95.CrossRef
2.
Ni H, Xu J. COPD-related mortality by sex and race among adults aged 25 and over: United States, 2000-2014. NCHS Data Brief. 2016;256:1-8.
3.
Macleod CM, Avery OT. The occurrence during acute infections of a protein not normally present in the blood: III. Immunological properties of the c-reactive protein and its differentiation from normal blood proteins. J Exp Med. 1941;73(2):191-200.CrossRef
4.
Miravitlles M, Moragas A, Hernández S, Bayona C, Llor C. Is it possible to identify exacerbations of mild to moderate COPD that do not require antibiotic treatment? Chest. 2013;144:1571-7.CrossRef
Metadata
Title
CRP-Guided Antibiotic Therapy for Acute COPD Exacerbation: a Randomized Control Trial
Authors
Jocelyn A. Carter, MD, MPH
Harry B. Burke, MD, PhD
Publication date
01-07-2021
Publisher
Springer International Publishing
Published in
Journal of General Internal Medicine / Issue 7/2021
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-020-06053-0

Other articles of this Issue 7/2021

Journal of General Internal Medicine 7/2021 Go to the issue

Original Research

Patient Experiences with Screening and Assistance for Social Isolation in Primary Care Settings

Review Paper

Reducing Inappropriate Proton Pump Inhibitors Use for Stress Ulcer Prophylaxis in Hospitalized Patients: Systematic Review of De-Implementation Studies

Original Research

Hospital-Level Care at Home for Acutely Ill Adults: a Qualitative Evaluation of a Randomized Controlled Trial

Original Research

Association Between the ACA Medicaid Expansions and Changes in Cardiovascular Risk Factors Among Low-Income Individuals

Concise Research Report

Accessibility of Virtual Visits for Urgent Care Among US Hospitals: a Descriptive Analysis

Exercises in Clinical Reasoning

Exercises in Clinical Reasoning: Digesting a Bloated Differential Diagnosis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits